Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Consolidated Net Income: 2009-2024

Historic Consolidated Net Income for Catalyst Pharmaceuticals (CPRX) over the last 16 years, with Dec 2024 value amounting to $163.4 million.

  • Catalyst Pharmaceuticals' Consolidated Net Income rose 20.28% to $52.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $217.1 million, marking a year-over-year increase of 65.79%. This contributed to the annual value of $163.4 million for FY2024, which is 174.43% up from last year.
  • Catalyst Pharmaceuticals' Consolidated Net Income amounted to $163.4 million in FY2024, which was up 174.43% from $59.5 million recorded in FY2023.
  • Catalyst Pharmaceuticals' Consolidated Net Income's 5-year high stood at $163.4 million during FY2024, with a 5-year trough of $39.5 million in FY2021.
  • Its 3-year average for Consolidated Net Income is $102.0 million, with a median of $83.1 million in 2022.
  • Per our database at Business Quant, Catalyst Pharmaceuticals' Consolidated Net Income plummeted by 47.35% in 2021 and then spiked by 174.43% in 2024.
  • Catalyst Pharmaceuticals' Consolidated Net Income (Yearly) stood at $75.0 million in 2020, then slumped by 47.35% to $39.5 million in 2021, then skyrocketed by 110.42% to $83.1 million in 2022, then fell by 28.34% to $59.5 million in 2023, then spiked by 174.43% to $163.4 million in 2024.